Mengis Capital Management, Inc. Novartis Ag Transaction History

Mengis Capital Management, Inc.

  • $467 Million
  • Q1 2025

A detailed history of Mengis Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 80,113 shares of NVS stock, worth $9.27 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
80,113
Previous 80,113 -0.0%
Holding current value
$9.27 Million
Previous $7.8 Million 14.56%
% of portfolio
1.91%
Previous 1.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
BUY
$96.78 - $117.18 $58,068 - $70,308
600 Added 0.75%
80,113 $7.8 Million
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $222,023 - $252,901
-2,092 Reduced 2.56%
79,513 $9.15 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $202,543 - $234,925
-2,188 Reduced 2.61%
81,605 $8.69 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $176,249 - $200,669
1,850 Added 2.26%
83,793 $8.11 Million
Q4 2023

Feb 01, 2024
BUY
$92.27 - $101.54 $27,681 - $30,462
300 Added 0.37%
81,943 $8.27 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $4,736 - $5,256
-50 Reduced 0.06%
81,643 $8.32 Million
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $16,191 - $18,359
-175 Reduced 0.21%
81,693 $8.24 Million
Q1 2023

May 05, 2023
BUY
$80.03 - $92.81 $6.55 Million - $7.6 Million
81,868 New
81,868 $7.53 Million
Q4 2022

Feb 01, 2023
SELL
$75.55 - $92.52 $35,508 - $43,484
-470 Reduced 0.57%
82,258 $7.46 Million
Q3 2022

Nov 04, 2022
SELL
$74.61 - $87.26 $233,753 - $273,385
-3,133 Reduced 3.65%
82,728 $6.29 Million
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $10,870 - $12,656
-135 Reduced 0.16%
85,861 $7.26 Million
Q1 2022

May 02, 2022
BUY
$80.11 - $90.62 $77,466 - $87,629
967 Added 1.14%
85,996 $7.55 Million
Q4 2021

Feb 04, 2022
BUY
$79.7 - $88.13 $187,295 - $207,105
2,350 Added 2.84%
85,029 $7.44 Million
Q3 2021

Nov 03, 2021
BUY
$81.78 - $95.14 $20,445 - $23,785
250 Added 0.3%
82,679 $6.76 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $143,799 - $158,831
1,687 Added 2.09%
82,429 $7.52 Million
Q1 2021

May 07, 2021
BUY
$83.5 - $98.47 $615,645 - $726,019
7,373 Added 10.05%
80,742 $6.9 Million
Q4 2020

Feb 03, 2021
BUY
$78.07 - $94.43 $3,435 - $4,154
44 Added 0.06%
73,369 $6.93 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $101,278 - $112,203
1,233 Added 1.71%
73,325 $6.38 Million
Q2 2020

Jul 22, 2020
BUY
$80.93 - $91.1 $1,780 - $2,004
22 Added 0.03%
72,092 $6.3 Million
Q1 2020

May 06, 2020
BUY
$70.67 - $99.01 $243,104 - $340,594
3,440 Added 5.01%
72,070 $5.94 Million
Q4 2019

Feb 06, 2020
SELL
$84.35 - $95.37 $28,088 - $31,758
-333 Reduced 0.48%
68,630 $6.5 Million
Q3 2019

Nov 05, 2019
SELL
$85.54 - $94.26 $4,277 - $4,713
-50 Reduced 0.07%
68,963 $5.99 Million
Q2 2019

Jul 18, 2019
BUY
$75.4 - $92.8 $3.23 Million - $3.97 Million
42,773 Added 163.01%
69,013 $6.3 Million
Q1 2019

May 06, 2019
SELL
$75.32 - $86.15 $5,272 - $6,030
-70 Reduced 0.27%
26,240 $2.52 Million
Q4 2018

Feb 06, 2019
SELL
$73.66 - $82.02 $7,366 - $8,202
-100 Reduced 0.38%
26,310 $2.26 Million
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $18,408 - $21,293
-275 Reduced 1.03%
26,410 $2.28 Million
Q2 2018

Jul 24, 2018
BUY
$64.91 - $73.36 $3,245 - $3,668
50 Added 0.19%
26,685 $2.02 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $54,247 - $58,230
750 Added 2.9%
26,635 $2.24 Million
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $1.92 Million - $2 Million
25,885
25,885 $2.22 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mengis Capital Management, Inc. Portfolio

Follow Mengis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email